In clinical studies, the cure rates for Glucantime injections have shown promising results. For instance, intramuscular injections demonstrated a recovery rate of approximately 84%, while intralesional injections had a slightly lower rate of 76% . This suggests that intramuscular administration may be more effective for treating cutaneous leishmaniasis.